Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma.
Rieke DT, Schröder S, Schafhausen P, Blanc E, Zuljan E, von der Emde B, Beule D, Keller U, Keilholz U, Klinghammer K.
Rieke DT, et al. Among authors: von der emde b.
Front Oncol. 2023 Jun 20;13:1107134. doi: 10.3389/fonc.2023.1107134. eCollection 2023.
Front Oncol. 2023.
PMID: 37427101
Free PMC article.